Project Grant R15AR080813

Award Date 8/1/22
Completion Date 7/31/25
Dollars Obligated $906K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Athens, OH 45701, USA
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) aims to define the systemic mechanisms by which adipose (fat) tissue communicates with the knee joint to drive the development of osteoarthritis (OA). The $1,476,001 award to the Regents of the University of California, San Francisco will fund a comprehensive investigation of three potential interorgan crosstalk pathways: signaling through...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $123,040 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to investigate the therapeutic role of the NFAT1 transcription factor in osteoarthritis. The 5-year project, which began on August 1, 2024, aims to evaluate the potential of AAV-delivered NFAT1 gene therapy in treating...
This $426,889 federal Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to investigate the molecular regulatory mechanisms of a cartilage-enriched G-protein coupled receptor (GPCR) named ADGRG6 in maintaining joint and cartilage homeostasis. The project aims to elucidate the role of ADGRG6 in regulating chondrocyte differentiation and...
This federal Project Grant award of $1,288,152 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop a transformative high-throughput screening approach to identify nanoparticles (NPs) that can target specific cell types in osteoarthritis (OA) joints. The project, titled "Exploring Nano-Bio Interactions for Cell-Specific Targeting of...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $221,866 Project Grant (R21AR085243) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Connecticut Health Center. The funding will support a study examining the association between alcohol-related metabolites and the risk of developing knee osteoarthritis. The research aims to identify metabolomic signatures of alcohol consumption that may predict...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $618,629 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Regents of the University of Colorado to establish a new "microphysiological joint-on-chip" system. The objective is to create a realistic human joint model that can support mechanistic study of arthritic diseases and rapid testing of candidate treatments. The researchers plan to develop...
This federal Project Grant award of $456,808.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) is supporting the development of advanced mass spectrometry imaging (MSI) technologies to spatially visualize proteins and glycans in musculoskeletal tissues. The primary awardee, the Buck Institute for Research on Aging, is collaborating with researchers at the University of...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Vanderbilt University a $393,412 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to develop engineered cells as agents for treating osteoarthritis. The project aims to leverage advanced cell design platforms to create synthetic receptor-controlled, joint-resident cells that can detect cartilage degeneration and then upregulate the expression of transgenes to promote...
The University of Pittsburgh was awarded a $1,657,392 federal Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research to repurpose FDA-approved drugs for the treatment of osteoarthritis (OA) using high-throughput screening in microphysiological models. The researchers will utilize three in vitro models - a cartilage model, a synovial...
This federal Project Grant award, valued at $126,164.00 and made by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the effects of obesity on Achilles tendon homeostasis and healing. The principal investigator, Dr. Zellers, is an assistant professor at Washington University School of Medicine and will leverage murine models of obesity and lipodystrophy to...

This three-year, $906,000 project grant from the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases will fund research into obesity-promoting protein malonylation and its role in chondrocyte metabolic dysfunction and osteoarthritis development. Specifically, the grantee - Ohio University - will investigate how obesity accelerates osteoarthritis through "carbon stress," which causes metabolic byproducts to accumulate in cartilage cells and decrease protein activity. They will test whether obesity promotes malonylation to accelerate osteoarthritis and determine how the SIRT5-malonylation pathway regulates cartilage degeneration under obesity-associated inflammatory conditions. Well-established mouse models and genetically modified mice will be used to examine the consequences of enhancing or inhibiting malonylation on osteoarthritis pathology. In vivo and in vitro metabolic profiling will assess effects on chondrocyte cellular metabolism. The research aims to provide a more comprehensive understanding of how obesity and aging damage joint cell metabolism and promote osteoarthritis, with the potential to identify new therapeutic targets.

Generated 1/7/24, 1:50 AM